Filing metadata

Accession number
0001214659-23-001038
Form type
Form 4
Filer
Mirati Therapeutics, Inc.
CIK
CIK 1576263
Filed
Jan 24, 2023
Reporting period
Jan 20, 2023
Description
Insider transaction

Explore SEC Filings Hub